Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver.

Bahde, Ralf

Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver. [electronic resource] - Hepatology (Baltimore, Md.) Jan 2013 - 320-30 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-3350

10.1002/hep.26005 doi


Animals
Bosentan
Cardiovascular Agents--pharmacology
Dipeptidyl Peptidase 4--deficiency
Endothelin Receptor Antagonists
Epoprostenol--pharmacology
Hepatocytes--drug effects
Lisinopril--pharmacology
Liver--blood supply
Losartan--pharmacology
Nitroglycerin--pharmacology
Rats
Rats, Inbred F344
Sulfonamides--pharmacology